When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - How ImmunoGen Trounced Analysts' Q4 Revenue and Earnings Estimates
ImmunoGen Inc.
If you liked the gains generated by ImmunoGen (NASDAQ: IMGN) in 2020, you're loving the stock in 2021. So far this year, the biotech's shares have soared 32%. And that momentum is now likely to build even more.
ImmunoGen announced its fourth-quarter results before the market opened on Friday. Investors liked what they saw. Here are the highlights of ImmunoGen's Q4 update.